Protherics PLC
Notification of Major Interests in Shares
London, UK; Brentwood, TN, US: 14 August 2008 - Protherics PLC
("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, announces that on 13
August 2008, in accordance with the Transparency Obligations
Directive, a notification of interest in the ordinary share capital of
the Company was received from AXA Investment Managers UK Limited on
behalf of AXA S.A. and its Group Companies ("AXA"). The notification
follows an increase in its Indirect Voting Rights. Details of
the interest notified are as follows:
1. Reason for the notification (please tick
the appropriate box or boxes)
A acquisition of voting rights X
An acquisition or disposal of financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
An event changing the breakdown of voting rights
Other (please specify):
2. Full name of person(s) subject to the AXA S.A., 25 Avenue
notification obligation: Matignon, 75008 Paris and
its group of companies.
3. Full name of shareholder(s) (if different
from 2.):
4. Date of the transaction (and date on which 12 August 2008
the threshold is crossed or reached if
different):
5. Date on which issuer notified: 13 August 2008
6. Threshold(s) that is/are crossed or 12%
reached:
7. Notified details:
A: Voting rights attached to shares
Class/ Situation previous Resulting situation after
type of to the Triggering the trigger transaction
shares transaction
if possible
using Number Number of Number Number of voting
the ISIN of Shares Voting of rights
CODE Rights Shares
Direct Direct Indirect Direct
0702920 41,926,236 41,926,236 941,666 941,666 41,084,570 0.28%
% of voting
rights
Indirect
12.01%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ Number of voting rights that % of
financial date Conversion may be acquired if the voting
instrument Period/ instrument is exercised/ rights
Date converted.
Total (A+B)
Number of voting rights % of voting rights
42,026,236 12.28%
8. Chain of controlled undertakings through which the voting rights and
/or the financial instruments are effectively held, if applicable :
Name of Company/Fund Number of % of issued
Shares share capital
AXA UK Investment Co ICVC 511,882 0.14960
UK Smaller Companies Fund
Indirect
Sun Life Pensions Management Ltd 225,000 0.06576
Direct
Sun Life Unit Assurance Ltd 53,913 0.01576
FTSE All Share Tracker
Direct
Sun Life Pensions Management 294,874 0.08618
FTSE All Share Tracker
Direct
AXA Framlington 425,000 0.12421
Indirect
AXA Framlington 1,851,468 0.54111
Indirect
AXA Framlington 1,909,918 0.55820
Indirect
AXA Framlington 459,865 0.13440
Indirect
AXA Framlington 639,353 0.18686
Indirect
AXA Framlington 15,438,453 4.51207
Indirect
AXA Framlington 13,753,131 4.01951
Indirect
AXA Framlington 2,000,000 0.58452
Indirect
AXA Framlington 1,500,000 0.43839
Indirect
AXA Framlington 500,000 0.14613
Indirect
AXA Framlington 220,000 0.06430
Indirect
Framlington onshore private clients 975,500 0.28510
Indirect
AXA Sun Life With Profits Passive 226,817 0.06629
Direct
AXA Sun Life With Profits Passive 141,062 0.04123
Direct
AXA Framlington 900,000 0.26304
Indirect
Total Direct 941,666 0.27521
Total Indirect 41,084,570 12.00745
TOTAL 42,026,236 12.28266
Proxy Voting:
9. Name of the proxy holder:
10. Number of voting rights proxy holder will cease to hold:
11. Date on which proxy holder will cease to hold voting rights:
12. Additional information:
/ Ends /
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com